Rand Capital Achieved Fifth Consecutive Year of Record

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Rand Capital Achieved Fifth Consecutive Year of Record Year-End Net Asset Value and Made Record Investments of $7.0 Million in 2015

BUFFALO, NY --(Marketwired - March 10, 2016) - Rand Capital Corporation ( NASDAQ : RAND )

  • Net asset value per share of $5.35 at year end, up 5% over prior year end
  • Total portfolio value of $36.8 million, up 22% over 2014 year end
  • Cash proceeds of approximately $14 million from sale of Gemcor, Rand's largest portfolio company, anticipated to occur in the first quarter of 2016 
  • 10-year compound annual growth in net asset value per share of 13.5% through year-end 2015

Rand Capital Corporation ( NASDAQ : RAND ) ("Rand"), a venture capital company that makes primarily equity investments in companies with emerging product, service or technology concepts, announced its results for the 2015 fourth quarter and full year ended December 31, 2015.

Allen F. ("Pete") Grum, President and Chief Executive Officer of Rand Capital, commented, "2015 was an exciting year for Rand on several fronts. First, we invested a record-breaking $7.0 million in promising opportunities, expanding our portfolio and offering equity appreciation potential. Second, we achieved record-breaking investment income of $2.8 million driven by the strong financial performance of our largest portfolio company, Gemcor. Third, we reached a record level of net asset value. Finally, subsequent to year end, we signed an agreement for the sale of Gemcor, one of our most successful portfolio companies to date, with the transaction expected to close in the first quarter of 2016. While we are pleased with these results, we are even more excited about the potential inherent in our existing portfolio and future investments as we effectively put additional capital to work."

Fourth Quarter and Full Year 2015 Financial Highlights

  • Achieved $5.35 net asset value (NAV) per share at December 31, 2015, up $0.24 per share, or 5%, over December 31, 2014
  • Invested $200,000 during the quarter with a follow-on investment in BeetNPath, LLC
  • Completed 23 financing transactions across 16 portfolio companies totaling $7.0 million in 2015
  • Increased investment portfolio fair value by 22% over prior year end, to $36.8 million at 2015 year end
  • Announced expected sale of Gemcor in first quarter of 2016

Strong Fourth Quarter Results in Record Year-end Net Asset Value 

  • Rand recorded $4.1 million of pretax unrealized gain relating to its investment in Gemcor II, LLC ( www.gemcor.com ), a Buffalo-area based, global leader in the development and manufacture of automated fastening systems used by virtually every airframe manufacturer throughout the world. The gain was based on the signed agreement for the sale of Gemcor, announced on January 5, 2016. Rand made its initial investment in Gemcor in 2004. Its equity cost basis is currently $625,000 and it expects to receive gross cash proceeds of approximately $14 million upon completion of the Gemcor sale, anticipated in the first quarter of 2016. At December 31, 2015, Gemcor represented approximately 38% of Rand's total portfolio, with a fair value of $13.8 million.
  • In the fourth quarter, Rand made a $200,000 follow-on investment in BeetNPath, LLC ( www.grainful.com ), an Ithaca, NY-based creator of frozen entrees and side dishes made from 100% whole grain steel cut oats. This investment took the form of Series A-2 Preferred Shares, following Rand's initial investment in 2014.
  • In accordance with its valuation policy, Rand also recorded unrealized market value net write-downs of $2.5 million in the fourth quarter of 2015. This included write-downs of $0.6 million for both Intrinsiq Materials, Inc. ( www.intrinsiqmaterials.com ) and First Wave Products Group, LLC ( www.firstwaveproducts.com ) as well as $0.5 million for SciAps, Inc. ( www.sciaps.com ). The Company determines the fair value of each of its investments in good faith, based on the specific facts and circumstances of each portfolio company, while applying a consistent valuation process. If the factors which led to the reductions in valuation are overcome in future periods, the valuations may be restored.

As of December 31, 2015, Rand's portfolio was valued at $36.8 million and consisted of 31 businesses. A diversified group of investments, the portfolio includes approximately 50% in manufacturing, 22% in software, 14% in healthcare and 14% in a diverse group of other industry categories. The portfolio is comprised of approximately 85% in equity investments and 15% in debt investments.

Liquidity and Capital Resources

Rand is focused on increasing net asset value through capital appreciation and maintaining sufficient cash flow to drive operational leverage.

Cash on hand at December 31, 2015 was $5.8 million. The primary use of cash is for follow-on and new investments to grow the Company's portfolio and net asset value as well as to fund the company's operations.

Strategy Update and Outlook

Rand's strategy has been to expand its net asset value by capitalizing on maturing investments and leveraging the returns to invest in early-stage companies with new or unique products or services that offer competitive advantage and strong growth potential. The Company's unique advantages are its focus on equity appreciation within its portfolio, its ability to provide smaller investments, its network of investment partners and growing opportunities in the undercapitalized, but strengthening markets of upstate New York and surrounding regions.

Mr. Grum concluded, "The 10-year compound annual growth rate of Rand's net asset value per share was 13.5% through the end of 2015. Capitalizing on this success, our growth strategy now entails broadening our network and geographic reach as we evaluate a growing pipeline of investment opportunities. Our goal is to achieve double-digit growth of our net asset value per share on average over the next five to ten years. We are also more committed than ever to being proactive about keeping our investors informed of the progress of our portfolio companies. We continue to be focused on maximizing shareholder value as we drive Rand to the next level." 

ABOUT RAND CAPITAL Rand Capital ( NASDAQ : RAND ) provides investors the ability to participate in venture capital opportunities through an investment in the Company's stock. Rand is a Business Development Company (BDC), and its wholly-owned subsidiary is licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). Rand focuses its investments in early or expansion stage companies with strong leadership that are bringing to market new or unique products, technologies or services that have a high potential for growth. Additional information can be found at the Company's website where it regularly posts information:  www.randcapital.com .

Safe Harbor Statement This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning the expected timing and completion of the Gemcor sale transaction, the expected cash proceeds of the transaction to Rand and Rand's plans for those proceeds when and if received. These statements involve known and unknown risks, uncertainties and other factors that could cause the actual results to differ materially from the results expressed or implied by such statements, including general economic and business conditions, the satisfaction or performance by the parties or otherwise of all conditions to closing of the Gemcor sale, and the timing and opportunity for investments of the sale proceeds among others. Consequently, such forward looking statements should be regarded as the Corporation's current plans, estimates and beliefs. The Corporation assumes no obligation to update the forward-looking information contained in this release.

FINANCIAL TABLES FOLLOW

   
Rand Capital Corporation and Subsidiary  
Consolidated Statements of Financial Position  
       
    December 31,  
    2015     2014  
ASSETS                
  Investments at fair value:                
    Control investments (cost of $1,141,472 and $1,347,300, respectively)   $ 13,916,472     $ 10,022,300  
    Affiliate investments (cost of $17,663,217 and $15,188,935, respectively)     14,662,219       14,617,378  
    Non-affiliate investments (cost of $8,606,053 and $5,677,241, respectively)     8,253,709       5,665,698  
  Total investments, at fair value (cost of $27,410,742 and $22,213,476,respectively)     36,832,400       30,305,376  
  Cash     5,844,795       13,230,717  
  Interest receivable (net of allowance: 2015: $122,000 and 2014: $128,311)     215,224       165,094  
  Prepaid income taxes     65,228       -  
  Other assets     1,804,040       1,824,800  
      Total assets   $ 44,761,687     $ 45,525,987  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY (NET ASSETS)                    
  Liabilities:                
  Debentures guaranteed by the SBA   $ 8,000,000     $ 8,000,000  
  Income tax payable     -       2,065,795  
  Deferred tax liability     2,361,186       1,838,351  
  Profit sharing and bonus payable     282,000       953,490  
  Accounts payable and accrued expenses     238,911       290,646  
  Deferred revenue     25,930       24,264  
      Total liabilities     10,908,027       13,172,546  
                 
  Stockholders' equity (net assets):                
  Common stock, $.10 par; shares authorized 10,000,000; shares issued6,863,034; shares outstanding of 6,328,538 as of 12/31/15 and 12/31/14     686,304       686,304  
  Capital in excess of par value     10,581,789       10,581,789  
  Accumulated net investment gain (loss)     (24,580 )     (867,482 )
  Undistributed net realized gain on investments     18,262,401       18,290,374  
  Net unrealized appreciation on investments     5,795,237       5,109,947  
  Treasury stock, at cost; 534,496 shares as of 12/31/15 and 12/31/14     (1,447,491 )     (1,447,491 )
      Total stockholders' equity (net assets) (per share: 2015: $5.35, 2014: $5.11)     33,853,660       32,353,441  
      Total liabilities and stockholders' equity   $ 44,761,687     $ 45,525,987  
                 
   
Rand Capital Corporation and Subsidiary  
Consolidated Statements of Operations  
                         
    For the Quarter Ended December 31,     For the Year Ended December 31,  
    2015     2014     2015     2014  
Investment income:                                
  Interest from portfolio companies:                                
    Control investments   $ 16,321     $ 23,799     $ 77,077     $ 112,218  
    Affiliate investments     75,806       106,163       388,135       481,649  
    Non-Control/Non-Affiliate investments     49,363       58,761       225,897       195,681  
      Total interest from portfolio companies     141,490       188,723       691,109       789,548  
  Interest from other investments:                                
    Non-Control/Non-Affiliate investments     3,329       3,765       22,048       14,288  
      Total interest from other investments     3,329       3,765       22,048       14,288  
  Dividend and other investment income:                                
    Control investments     371,628       514,824       1,735,934       1,549,185  
    Affiliate investments     221,674       108,658       345,913       198,723  
    Non-Control/Non-Affiliate investments     -       -       -       2,531  
      Total dividend and other investment income     593,302       623,482       2,081,847       1,750,439  
Fee income:                                
  Control investments     2,000       2,000       8,000       12,000  
    Affiliate investments     1,416       4,399       4,666       8,866  
    Non-Control/Non-Affiliate investments     4,250       3,251       16,667       9,334  
      Total fee income     7,666       9,650       29,333       30,200  
Total investment income     745,787       825,620       2,824,337       2,584,475  
                                 
Operating expenses:                                
  Salaries     149,555       147,669       598,220       590,675  
  Bonus and profit sharing     122,500       981,979       122,500       936,344  
  Employee benefits     30,391       80,621       117,937       169,808  
  Directors' fees     40,000       24,000       129,000       112,500  
  Professional fees     74,990       38,504       202,194       164,740  
  Stockholders and office operating     65,601       24,066       222,431       133,505  
  Insurance     6,132       8,100       32,086       35,709  
  Corporate development     14,190       22,549       62,553       64,490  
  Other operating     14,357       13,475       23,330       19,116  
      517,716       1,340,963       1,510,251       2,226,887  
  Interest on SBA obligations     77,568       70,439       307,028       266,099  
  Bad debt expense     -       -       -       6,311  
  Total operating expenses     595,284       1,411,402       1,817,279       2,499,297  
Net investment gain (loss) before income taxes     150,503       (585,782 )     1,007,058       85,178  
  Income tax (benefit) expense     (98,129 )     (28,738 )     164,156       63,343  
Net investment gain (loss)     248,632       (557,044 )     842,902       21,835  
Net realized (loss) gain on sales and dispositions of investments:                                
  Affiliate investments     (300,000 )     -       (300,000 )     (617,619 )
  Non-Control/Non-Affiliate investments     (5,394 )     8,302,495       257,531       7,855,556  
  Net realized (loss) gain before income taxes     (305,394 )     8,302,495       (42,469 )     7,237,937  
  Income tax (benefit) expense     (104,238 )     2,833,809       (14,496 )     2,470,453  
  Net realized (loss) gain on sales and dispositions of investments     (201,156 )     5,468,686       (27,973 )     4,767,484  
Net increase (decrease) in unrealized appreciation on investments :                                
  Control investments     4,100,000       -       4,100,000       5,336  
  Affiliate investments     (1,986,004 )     (300,000 )     (2,429,440 )     (270,020 )
  Non-Control/Non-Affiliate investments     (534,373 )     (1,138,254 )     (340,801 )     (97,160 )
  Change in unrealized appreciation before income taxes     1,579,623       (1,438,254 )     1,329,759       (361,844 )
  Deferred income tax expense (benefit)     736,021       (494,488 )     644,469       (114,006 )
  Net increase (decrease) in unrealized appreciation on investments     843,602       (943,766 )     685,290       (247,838 )
Net realized and unrealized gain on investments     642,446       4,524,920       657,317       4,519,646  
Net increase in net assets from operations   $ 891,078     $ 3,967,876     $ 1,500,219     $ 4,541,481  
Weighted average shares outstanding     6,328,538       6,338,411       6,328,538       6,391,175  
Basic and diluted net increase in net assets from operations per share   $ 0.14     $ 0.63     $ 0.24     $ 0.71  
                                 

Contacts: Company: Allen F. ("Pete") Grum President and CEO Phone: 716.853.0802 Email:  pgrum@randcapital.com Investors: Deborah K. Pawlowski  Kei Advisors LLC  Phone: 716.843.3908  Email:  dpawlowski@keiadvisors.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 226

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Vector's Peptide Pact Needs Proof Before Any Payday

Updated Category News Views 174

A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...

Continue Reading
Sunbit’s 2027 Loan Push Meets an NVIDIA-Fueled Tape

Updated Category News Views 116

Credit Is About to Enter Sunbit’s Growth Story Sunbit has spent years building a point-of-sale fintech footprint, and the numbers it cited on November 18 make the next step harder to dismiss as mere marketing fluff. The company says it has topped 400,000 activated cardholders and 50,000 merchants, while expecting more than $440 million in fiscal 2026 sales on greater...

Continue Reading
Lummus-Versalis Deal Adds Nine Elastomer Technologies

Updated Category News Views 93

Nine elastomer technologies do not make a flashy headline, yet this is the sort of chemical-industry move that can matter long after the applause dies down. Lummus Technology and Versalis have expanded their partnership to cover nine elastomer technologies. That is the disclosed fact, and it is meaningful on its own. The release does not lay out contract value, duration,...

Continue Reading
DigiKey’s Arduino Webinar Puts Edge AI Hardware to Work

Updated Category News Views 62

A Small Board With a Big Practical Question Edge AI is finally getting dragged out of the slide deck and onto the workbench, which is where it ought to prove itself. DigiKey plans to host a free 60-minute webinar on Dec. 2, 2026, at 10 a.m. CST covering Arduino’s new VENTUNO Q edge AI computer. The session promises a hardware tour, an Arduino App Lab walkthrough, and a...

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 167

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 49

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 30

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 201

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
BetterInvesting Puts ELMD and FIVE Under a Fresh Lens

Updated Category News Views 74

Two familiar market traps are hiding in this otherwise useful announcement: mistaking a study candidate for a buy signal, and treating the word undervalued like it fell from a mountaintop. BetterInvesting has named Electromed Inc. as its “Stock to Study” and Five Below Inc. as its “Undervalued Stock” for the January-February 2027 issue of its magazine. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Balaji Srinivasan Links Bitcoin to Wealth and Health Preservation

Updated Category News Views 54

Balaji Srinivasan's Views on Bitcoin's Role Balaji Srinivasan, the former CTO of Coinbase, has been in the spotlight for his insights on how Bitcoin can help protect personal wealth. He draws a compelling comparison between Bitcoin and the pursuit of longevity in healthcare, suggesting both serve as defenses against state control over personal lives. Bitcoin as a Shield...

Continue Reading
Sequana Medical to Host Webinar on alfapump Commercial Launch

Updated Category News Views 213

Sequana Medical's Upcoming KOL Webinar on alfapump Launch Sequana Medical is set to host a Key Opinion Leader (KOL) webinar focused on the alfapump, designed for tackling recurrent and refractory ascites due to liver cirrhosis. This engaging session will take place on January 8. Experts from esteemed institutions will dive into vital discussions about the alfapump's...

Continue Reading
Qualcomm's Strategies to Navigate Competitive Market Pressures

Updated Category News Views 196

Qualcomm's Strong Market Position Despite Challenges Qualcomm Inc (NASDAQ: QCOM) has shown impressive resilience in the market, achieving significant growth largely due to its core chip business, which has seen double-digit growth. This is an encouraging sign of ongoing demand for its technology, particularly with high-end Android devices and innovations within artificial...

Continue Reading
Healthcare Providers Speak: A Study on Challenges and Care

Updated Category News Views 216

Healthcare Providers Speak: A Study on Challenges and Care Shapiro+Raj, a premier insights and strategy consultancy, has unveiled a significant study titled The Provider Perspective: Insights on Policy, Practice, and Patient Care. This comprehensive four-part series delves into the experiences of healthcare providers in the United States, highlighting their readiness to...

Continue Reading
PBOC Executes Groundbreaking Swap Operation of 50 Billion Yuan

Updated Category News Views 101

PBOC's Innovative Swap Operation The People's Bank of China (PBOC) has made waves in the financial sector by executing its very first swap operation involving a remarkable 50 billion yuan, equivalent to approximately 7.03 billion dollars. This pivotal event took place on a Monday, signifying a strategic move in China's monetary policy. Significance of the Swap Operation...

Continue Reading